Sarcopenia Clinic for COPD Patients
This study is looking at how a special clinic for sarcopenia (skeletal muscle loss) in people with COPD (a lung disease that blocks airflow and makes it hard to breathe) might improve their health. Sarcopenia is common in COPD patients and can lead to serious problems. The study compares a multidisciplinary clinic, which includes a team of specialists like a lung doctor and nurse, to standard COPD care. The goal is to see if this specialized clinic can better diagnose and treat sarcopenia, leading to fewer hospitalizations, fewer COPD flare-ups, and improved survival for patients. You might be able to join if you are over 40, have COPD, and were recently hospitalized for a COPD exacerbation (a sudden worsening of symptoms) with evidence of low muscle mass on a CT scan.
- Study design
- This is an interventional study comparing a multidisciplinary sarcopenia clinic to standard COPD care. It plans to enroll 80 participants.
- What's involved
- Patients will be seen as a hospital follow-up appointment in either the multidisciplinary sarcopenia clinic or an outpatient ambulatory COPD clinic.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for one year after their initial visit.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Implementation of a Sarcopenia Clinic to Diagnose and Treat Skeletal Muscle Loss Due to COPD
At a glance
Conditions
Where it's being run
1 sites across 1 statesStudy leadership
- Amy Attaway, MD · PRINCIPAL_INVESTIGATOR · The Cleveland Clinic
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- MortalityOne year follow up
Count
- HospitalizationsOne year follow up
Count
- Number of COPD exacerbationsOne year follow up
Count